Skip to Main Content

Paper Details

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.
J Thorac Oncol
62
2021
Author NameAffiliation
Lixia DiaoThe University of Texas MD Anderson Cancer Center
Daniel J McGrailThe University of Texas MD Anderson Cancer Center
Linghua WangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianhua ZhangThe University of Texas MD Anderson Cancer Center
Jianjun ZhangThe University of Texas MD Anderson Cancer Center
  • 1 - 6

Datasets

Release 1.2